Cytokeratin 19 Polyclonal Antibody, PE Conjugated
Product Specifications
Background
Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
Synonyms
Keratin, type I cytoskeletal 19; KRT19; Cytokeratin-19; CK-19; Keratin-19; K19
Gene ID
3880
Swiss Prot
P08727
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human
Immunogen
168-270/400
Target
Cytokeratin 19
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE
Source
KLH conjugated synthetic peptide derived from human CK19
Applications
WB, FCM, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
496,564nm/578nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), FCM (1:20-100), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
3880
Predicted Cross Reactivity
Mouse, Rat, Dog, Cow, Pig, Horse, Chicken, Rabbit
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15134829 1 Vial
Lentiviral human TACC2 shRNA (UAS) - Lentiviral human TACC2 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
